title: Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
authors.affiliation: Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand. RichardG@cdhb.govt.nz
authors.forename: Richard
authors.initials: R
authors.lastname: Gearry
authors.forename: Murray
authors.initials: M
authors.lastname: Barclay
authors.forename: Christopher
authors.initials: C
authors.lastname: Florkowski
authors.forename: Peter
authors.initials: P
authors.lastname: George
authors.forename: Trevor
authors.initials: T
authors.lastname: Walmsley
mesh_terms: D015415:Biomarkers / Q000032:analysis; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis; D003937:Diagnosis, Differential; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces / Q000737:chemistry*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis*; D043183:Irritable Bowel Syndrome / Q000175:diagnosis; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis*; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex